Stay updated on Relamorelin in Diabetic Gastroparesis Clinical Trial
Sign up to get notified when there's something new on the Relamorelin in Diabetic Gastroparesis Clinical Trial page.

Latest updates to the Relamorelin in Diabetic Gastroparesis Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe ClinicalTrials.gov record for the relamorelin diabetic gastroparesis study is displayed instead of a 403 error page, with its study details and results information available.SummaryDifference89%

- Check18 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0; the study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check25 days agoChange DetectedA banner announces NIH’s transition from using the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs. It appears above the study record page, which displays a 403 error.SummaryDifference1%

- Check32 days agoChange DetectedThe site footer revision indicator changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check39 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check60 days agoChange DetectedRevision: v3.7.0 was added to the page. A broad set of terms and keywords related to the study and related conditions were removed from the page, and revision history metadata was updated.SummaryDifference17%

Stay in the know with updates to Relamorelin in Diabetic Gastroparesis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Relamorelin in Diabetic Gastroparesis Clinical Trial page.